alexcaps

https://www.inknowvation.com/sbir/companies/solgene-therapeu...

“ Solgene Therapeutics' patented drug-delivery technology enables the encapsulation, in a porous ceramic material, of living cells that secrete therapeutic compounds. After implantation, the material shields the encapsulated cells from the host's immune system while allowing passage of nutrients and therapeutic cell-secreted compounds. Implanted cells continue to function, thus mimicking natural processes. Solgene believes it can create competitive advantages in under-served biotech markets. It seeks revenues through alliances to commercialize hard-to-deliver, cell-secreted, large-molecule therapies. Solgene proved its concept by overcoming diabetes in diabetic mice. Target applications include delivery of livestock therapies, growth factors for bone healing, and a cell-secreted HIV therapy.”